RxDoctor Payments DataLook up a doctor →

Courtney Nelson, DO

Family Medicine · Layton, UTNPI 1205915410

Payments from drug & device makers

$190,500in general payments, 2019–2025

Across 1,145 payments — averaging $166.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$105K
  • Supernus Pharmaceuticals, Inc.$73K
  • Pfizer$2K
  • Biohaven Pharmaceuticals, Inc.$1K
  • Amgen$980
  • AstraZeneca$775
  • plus $8K from 54 others
$500in research payments, 2019–2025

Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Lucid Diagnostics Inc.$500

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)414$105,006
Supernus Pharmaceuticals, Inc.139$72,602
Pfizer16$1,588
Biohaven Pharmaceuticals, Inc.6$1,269
Amgen(2 entities)26$980
AstraZeneca42$775
Lilly USA, LLC60$746
Amarin Pharma, Inc.45$576
Otsuka America Pharmaceutical, Inc.24$543
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)14$537
E.r. Squibb & Sons, L.L.C.20$490
Boehringer Ingelheim23$448
Sunovion Pharmaceuticals Inc.28$434
Astellas Pharma US Inc22$411
Novo Nordisk18$331
Eisai Inc.22$319
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC25$294
Biohaven Pharmaceutical Holding Company Ltd.7$270
GSK18$260
Johnson & Johnson16$241
Takeda Pharmaceuticals U.S.A., Inc.26$238
Abbott18$217
Axsome Therapeutics, Inc.4$198
Sanofi-aventis U.S. LLC15$182
Teva Pharmaceuticals USA, Inc.11$147
Idorsia Pharmaceuticals US Inc2$111
Merck6$95
Avanir Pharmaceuticals, Inc.6$91
Neurelis, Inc.6$87
Alkermes, Inc.5$82
Nestle Healthcare Nutrition Inc.4$75
Optinose US, Inc.4$70
Sumitomo Pharma America, Inc.5$67
Lucid Diagnostics Inc.4$58
Genentech USA, Inc.3$49
Organon4$45
Neurocrine Biosciences, Inc.2$44
Seqirus USA Inc3$39
Shire North American Group Inc3$36
Tris Pharma Inc2$34
Sanofi Pasteur Inc.2$33
Cranial Technologies, Inc2$32
Lundbeck LLC2$31
Biogen2$30
Novartis2$27
Mylan Specialty L.p.1$21
Xeris Pharmaceuticals, Inc.1$19
Kowa Pharmaceuticals America, Inc.1$18
Grifols USA, LLC1$18
Aerin Medical Inc.1$18
Bolton Medical Inc1$17
Assertio Therapeutics, Inc.1$16
Jazz Pharmaceuticals Inc.1$16
Tandem Diabetes Care, Inc.1$15
Currax Pharmaceuticals LLC1$14
Boston Scientific1$14
Exact Sciences1$13
Bausch Health US, LLC1$13
Dexcom, Inc.1$12
Nalpropion Pharmaceuticals LLC1$12

How this compares

$190,500 in reported general payments places this provider in the 95th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$41,009
Medicare patients
98
Services billed
1,828

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Layton

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →